Cannabidiol: Difference between revisions

(5 intermediate revisions by 2 users not shown)

Line 97:

*'''Switzerland:''' Cannabidiol is not subject to the Narcotics Act in Switzerland because it does not produce a psychoactive effect. It is still subject to standard Swiss legislation.<ref>Swiss Agency for Therapeutic Products. (2017, August 1). Retrieved from https://www.swissmedic.ch/aktuell/00673/03778/index.html?lang=en</ref>

*'''United Kingdom:''' In 2016, the Medicines and Healthcare products Regulatory Agency (MHRA) issued a statement that products containing CBD used for medical purposes are considered as a medicine subject to standard licensing requirements.<ref>{{Citation | title=MHRA statement on products containing Cannabidiol (CBD) | url=https://www.gov.uk/government/news/mhra-statement-on-products-containing-cannabidiol-cbd}}</ref>

*'''United States:''' Cannabidiol is legal under the [https://www.fda.gov/news-events/public-health-focus/fda-regulation-cannabis-and-cannabis-derived-products-including-cannabidiol-cbd#farmbill ~~2018 Farm Bill] for anyone to purchase, but many stores limit the sale to people 18 or older.~~. The rest of the [[cannabis]] plant (anything with more than 0.3% Delta-9-THC) is still under Schedule I of the Controlled Substances Act.{{citation needed}}

*'''United States:''' Cannabidiol is legal under the 2018 Farm Bill<ref>https://www.fda.gov/news-events/public-health-focus/fda-regulation-cannabis-and-cannabis-derived-products-including-cannabidiol-cbd#farmbill</ref>. The rest of the [[cannabis]] plant (anything with more than 0.3% Delta-9-THC) is still under Schedule I of the Controlled Substances Act.{{citation needed}}

==External links==

@@ Line 97: / Line 97: @@
 *'''Switzerland:''' Cannabidiol is not subject to the Narcotics Act in Switzerland because it does not produce a psychoactive effect. It is still subject to standard Swiss legislation.<ref>Swiss Agency for Therapeutic Products. (2017, August 1). Retrieved from https://www.swissmedic.ch/aktuell/00673/03778/index.html?lang=en</ref>
 *'''United Kingdom:''' In 2016, the Medicines and Healthcare products Regulatory Agency (MHRA) issued a statement that products containing CBD used for medical purposes are considered as a medicine subject to standard licensing requirements.<ref>{{Citation | title=MHRA statement on products containing Cannabidiol (CBD) | url=https://www.gov.uk/government/news/mhra-statement-on-products-containing-cannabidiol-cbd}}</ref>
-*'''United States:''' Cannabidiol is legal under the [https://www.fda.gov/news-events/public-health-focus/fda-regulation-cannabis-and-cannabis-derived-products-including-cannabidiol-cbd#farmbill 2018 Farm Bill] for anyone to purchase, but many stores limit the sale to people 18 or older.. The rest of the [[cannabis]] plant (anything with more than 0.3% Delta-9-THC) is still under Schedule I of the Controlled Substances Act.{{citation needed}}
+*'''United States:''' Cannabidiol is legal under the 2018 Farm Bill<ref>https://www.fda.gov/news-events/public-health-focus/fda-regulation-cannabis-and-cannabis-derived-products-including-cannabidiol-cbd#farmbill</ref>. The rest of the [[cannabis]] plant (anything with more than 0.3% Delta-9-THC) is still under Schedule I of the Controlled Substances Act.{{citation needed}}
 ==External links==